Synthesis, hemilability, and catalytic transfer hydrogenation activity of iridium(III) and ruthenium(II) complexes containing oxygen-functionalised triazolylidene ligands by Pretorius, René et al.
1	
	
Synthesis, hemilability, and catalytic transfer hydrogenation activity of iridium(III) and 
ruthenium(II) complexes containing oxygen-functionalised triazolylidene ligands  
 
René Pretorius,a,b Zahra Mazloomia, and Martin Albrecht*a,b 
 
aDepartment of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, 
Switzerland. E-mail: martin.albrecht@dcb.unibe.ch 
bSchool of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland 
 
Dedicated to Gerard van Koten on the occasion of his 75th birthday and in admiration of his 
pioneering and inspiring contributions to organometallic chemistry and catalysis 
 
Abstract 
The synthesis and characterisation of iridium(III) and ruthenium(II) complexes bearing pendant 
hydroxy- and ether-wingtip substituents is described. Both monodentate and C,O-bidentate binding 
modes were observed for these O-functionalised triazolylidene complexes. The two bonding modes are 
interconvertible, which demonstrates the hemilability of this coordinating group. The catalytic activity 
of the complexes was compared in transfer hydrogenation, revealing that pendant hydroxy-
functionalities are beneficial for enhancing the performance of triazolylidene iridium(III) catalysts, 
while they have no effect in ruthenium-catalysed transfer hydrogenation. Accordingly, this functional 
group may serve as a probe to distinguish inner sphere from outer sphere transfer hydrogenation. 
 
 
Highlights: 
- New oxygen-functionalised ruthenium and iridium triazolylidene complexes 
- Hydroxy group is hemilabile 
- Hydroxy group accelerates hydrogen transfer catalysis mediated by iridium(III) 
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Introduction 
Pincer complexes have made one of the most fundamental contributions to the development of 
modern organometallic chemistry.[1] In pioneering work, van Koten and coworkers explored the 
consequences of combining hard amine donor sites with soft metals such as iridium(I) and platinum(II) 
nuclei,[2] which lead to a plethora of fascinating applications. Building on this fundamental design 
concept, we became interested in modifying N-heterocyclic carbenes (NHCs), a classic ligand scaffold 
of modern catalyst design as NHCs much like pincer ligands typically impart high thermal stability and 
countless options for synthetic modifications.[3] Introducing functional groups on the ligand scaffold 
allows for imparting stability through chelation, or hemilability for catalyst activation, or even 
bifunctional catalysis in which both the ligand and the metal participate in the conversion of 
substrate.[4] Prototypical examples of such functionalised catalysts include Shvo[5] and Noyori’s[6] 
(de)hydrogenation catalysts, which have excellent activity in an extended range of applications.[7]  
Based on these considerations, several examples of O- and N-functionalised Arduengo-type 
carbene complexes have been developed that display cooperative behaviour and enhanced catalytic 
properties.[8] Such functionalisation is even more versatile with 1,2,3-triazolylidene ligands,[9] as the 
core heterocycle is generally assembled via functional group-tolerant ‘click’ cycloaddition reaction of 
azides and alkynes.[10] Triazolylidene ligands that are N1,N3-disubstituted are mesoionic[11] and have 
been shown to stabilize high and low metal oxidation states.[12] They impart excellent catalytic activity 
in numerous transformations including cross-coupling,[13] and in particular redox transformations such 
as water oxidation,[14] amine and alcohol oxidation[15] and transfer hydrogenation.[16] While much 
recent work has been focusing on C,N-chelating triazolylidene complexes with imine donor sites, much 
less work has been directed towards understanding the catalytic implications of oxygen donors as 
functional groups at the triazolylidene ligand scaffold.[17] Due to the demonstrated benefits of oxygen 
functional groups in close proximity to the metal centre, we have designed triazolylidene metal 
complexes with a potential C,O-bidentate bonding motif.[8e,18] Herein we describe the synthesis of O-
functionalised 1,2,3-triazolylidene iridium(III) and ruthenium(II) complexes and their catalytic activity 
in transfer hydrogenation. Specifically, we sought to introduce pendant oxygen-wingtip groups adjacent 
to the carbene, to investigate hemilabile coordination and potential metal-ligand cooperative behaviour 
in hydrogen transfer for (de)hydrogenation processes.  
 
Results and Discussion 
Synthesis and characterisation of 1,2,3-triazolylidene iridium(III) complexes. The hydroxy-
functionalised ligand precursor 1 was prepared by literature procedures (Scheme 1).[18d] For the 
synthesis of the ether-functionalised triazolylidene precursor 2, a Williamson ether synthesis using NaH 
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and MeI was applied at the triazole stage to install the methyl ether, followed by triazole N-alkyation 
with [Me3O]BF4, which afforded the triazolium salt 2 in high yields (74%). Conveniently, NaH was 
used as the commercially available oil dispersion without any negative impact on yield. The purity of 
the crude triazole intermediate was not an issue as any oil residues were readily washed off from the 
final triazolium product after subsequent N-alkylation. The iridium(III) complexes 3–5 were 
synthesised by transmetallation procedures from the corresponding triazolium salt 1 or 2, using Ag2O 
(2 equiv) and Me4NCl (1 equiv) to form the Ag-carbene intermediates and subsequent in situ 
transmetallation with [Ir(Cp*)Cl2]2 (0.38 equiv). This procedure yielded iridium complexes 3–4 when 
starting from the hydroxy-functionalised ligand precursor 1, and complexes 5a,b when starting from 
triazolium salt 2 with an ether wingtip group. All complexes were obtained in spectroscopically pure 
form after separation by column chromatography, except for regioisomers 4 and 4’, which were not 
attempted to be separated any further. Satisfactory yields of ca. 40% were achieved for the desired O-
functionalised iridium complexes, 3a and 5a. Complexes 3b and 5b were obtained in variable yields 
and purity from this transmetallation protocol. Oxygen chelation and formation of complexes 3b and 
5b was more reliably achieved upon reaction of the monodentate triazolylidene complexes 3a and 5a, 
respectively, with AgBF4 as chloride scavenger.  
 
 
Scheme 1 Synthesis of 1,2,3-triazolylidene iridium(III) complexes 3–5. 
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Regioisomers 4 and 4’ were obtained in addition to the O-functionalised complexes 3a,b, as a 
consequence of wingtip degradation and formal loss of acetone, a reactivity pattern of this triazolium 
salt that was observed previously in the presence of Ag2O in attempts to transmetallate to gold(I).[18d] 
These results support the hypothesis that degradation of this wingtip group is Ag-mediated. The 
regioisomers were isolated in a 1:1 mixture and were used without further separation for subsequent 
applications. Consequently, two sets of resonances were observed in both 1H and 13C NMR spectra and 
assignments were made using 2-dimensional spectroscopy, including nuclear Overhauser effect 
spectroscopy (NOESY). The appearance of two low-field Ctrz–H resonances at δH = 7.49 and 7.51 in 
the 1H NMR spectrum is diagnostic for the loss of the C–4 wingtip group and confirmed the formation 
of complexes 4 and 4’. Also the carbenic chemical shifts for complexes 4 and 4’ (δC = 148.4 and 147.9) 
are well within the range reported for related triazolylidene iridium complexes. [14,15,19]  
Triazolylidene bonding in a monodentate or C,O-bidentate mode in complexes 3a/5a and 3b/5b, 
respectively, was identified by the distinct 1H NMR spectroscopic characteristics of these complexes. 
The NCH2 hydrogens of the monodentate coordinated triazolylidene in complexes 3a and 5a are 
diastereotopic and separated by ca. 1 ppm (δH = 4.93 and 4.09 for 3a, and multiplets centred at δH = 
4.95 and 4.09 for 5a). In contrast, this group appears in the chelating triazolylidene complex 3b as a 
broad singlet at δH = 4.45, and in complex 5b as two resonances with only 0.2 ppm shift difference 
(multiplets around δH = 4.5 and 4.3 ppm). In addition the 13C NMR signals due to the triazolylidene 
carbons appear at 3–9 ppm higher field in the monodentate triazolylidenes (δC = 145.5 and 152.9 in 3a, 
and 146.7 and 150.2 in 5a) when compared to the chelating triazolylidene complexes (δC = 154.1 and 
157.2 in 3b, and 151.5 and 153.0 in 5b). This shift correlates with the lower donor properties of the O-
functionalities in comparison to the chloride ligand, resulting in a deshielding of the triazole carbons. 
Likewise, the 13C resonances corresponding to the quaternary carbons of the tert–butyl group undergo 
a diagnostic shift upon chelation and appear at δC = 77.6 and 81.5 ppm, for 3b and 5b, respectively (cf. 
69.0 and 76.5 ppm, for 3a and 5a, respectively), in agreement with a reduced electron density on the 
oxygen atom upon coordination to the metal centre.[20]	
Chelation of the triazolylidene ligand in complexes 3b and 5b was further supported by chloride 
abstraction experiments performed with the monodentate triazolylidene complexes 3a and 5a. For 
example, reaction of these complexes with AgBF4 (1 equivalent) in CH2Cl2 solution yielded complexes 
3b and 5b, as corroborated by 1H NMR spectroscopy. Similarly, when NaBPh4 was used as the chloride 
scavenging agent, the highly diastereotopic NCH2 hydrogens merged characteristically to a singlet for 
complexes 3b and 5b. While most NMR resonances are identical to those obtained from 3b, the use of 
BPh4– counterion leads in addition to a 1:1 molar ratio between the metal complex and phenyl groups 
of the BPh4– anion (Supplementary Material, pages S10, S17), indicating that alternative chloride 
scavengers yield the same type of cationic chelate complexes.  
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Finally, the presence of the acidic OH protons in both 3a and 3b was confirmed by D2O exchange 
experiments, which induced disappearance of the resonances at δH = 6.21 and 3.39 ppm for 3a and 3b 
respectively (CD2Cl2 solution). Interestingly, monocationic complexes analogous to 3b could not be 
synthesised from closely related O-functionalised imidazolylidene iridium complexes (though MeCN 
was used as solvent in lieu of CH2Cl2).[8e]  
Unambiguous evidence for the proposed structures was obtained from single crystal X-ray analyses 
of complexes 3a,b and 5a (Fig. 1, Table 1). The molecular structures show the typical piano-stool 
arrangement around iridium(III), and general metrics are unexceptional.[14,15,19] Analysis of the 
monodentate triazolylidene complexes 3a and 5a reveals only slight deviations of bond lengths and 
angles between these complexes. Complex 3b, in contrast, displays C,O-bidendate coordination of the 
triazolylidene through both an Ir–Ccarbene and an Ir–O bond. The bond lengths vary only slightly upon 
chelation. The Ir–C and Ir–Cl bonds are contracted by ca. 0.04 Å in 3b when compared to 3a (e.g. Ir–
C1 2.032(4) vs 2.077(3) Å), presumably as a consequence of the formally cationic nature of the metal 
centre in 3b. Also, as a consequence of chelation, the Ir–C1–C2 angle in 3b is smaller than the 
corresponding angle in 3a (119.1(3) vs 136.7(2)°). This distortion is compensated by and inverse trend 
in the Ir–C1–N1 angle (increasing to 138.1(3)° in 3b vs. 121.54(19)° in 3a). Accordingly, the overall 
yaw angle is only marginally affected with 7.6° for 3a and 9.0° for 3b. Intramolecular H-bonding is 
observed in complex 3a between the hydroxy functionality and the metal-bound chloride with a O–
H…Cl donor-acceptor distance of 3.06 Å and a 166.2° hydrogen bond angle, thus forming a 7-
membered metallacycle. Complex 3b displays H-bonding between the coordinated alcohol and the non-
coordinating BF4– anion with a O–H…F donor-acceptor distance of 2.63 Å and an angle of 174°. These 
H…X interactions fall within the range expected for moderate-strength H-bonds.[21] The Ir–O bond 
length in complex 3b is 2.225(3) Å, slightly longer than the analogous bond distance in a related 
[Ir(Cp*)(trz-py)(OH2)]2+ complex (cf. 2.166(3) Å),[19a] and at the upper end of related NHC 
iridium(III) complexes (Ir–O bond in 2.15–2.24 Å range).[8e,22] The relatively long Ir–O bond in 3b 
has been attributed to the high steric bulk of the tert-butyl wingtip group. 
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Figure 1: ORTEP representations of complex 3a (a; only one of the two independent molecules shown), 
complex 3b (b) and complex 5a (c; all structures at 50% probability, disorder and hydrogen atoms 
omitted for clarity). 
 
Table 1 Selected bond distances (Å) and angles (°) for complexes 3a, 3b and 5a. 
 3a   (X = Cl2)a) 3b   (X = O) 5a   (X = Cl2) 
Ir–C1 2.077(3) 2.032(4) 2.082(3) 
Ir–Cl1 2.4237(7) 2.3779(10) 2.4184(8) 
Ir–X 2.4271(7) 2.225(3) 2.4448(9) 
C1–C2 1.403(4) 1.380(5) 1.405(5) 
Ir-Centroid 1.807 1.785 1.814 
    
C1–Ir–X 89.43(7) 73.61(12) 89.22(10) 
C1–Ir–Cl1 92.13(8) 86.29(10) 89.67(10) 
Cl1–Ir–X 86.33(3) 86.46(9) 84.02(10) 
Ir–C1–C2 136.7(2) 119.1(3) 136.0(3) 
Ir–C1–N3 121.54(19) 138.1(3) 121.9(2) 
7	
	
a Data only for one of the two (essentially identical) crystallographically independent molecules in the 
unit cell.  
 
Synthesis and characterisation of O-functionalised 1,2,3-triazolylidene ruthenium(II) 
complexes. The synthetic methodology developed for O-functionalised triazolylidene iridium(III) 
complexes was successfully extrapolated to prepare analogous ruthenium(II) complexes. Thus, 
ruthenium complexes 6 and 7 were synthesised from ligand precursor 1 using ([Ru(p-cymene)Cl2] (0.3 
equivalents) instead of [Ir(Cp*)Cl2]2 for transmetallation (Scheme 2). Purification by column 
chromatography yielded complexes 6a,b and 7. Alternatively, complex 6a was isolated selectively in 
up to 60% yield through an aqueous extraction of the crude reaction mixture followed by salting out 
the complex into CH2Cl2. This method of purification was applicable because in contrast to 6a, 
complexes 7/7’ are insoluble in water. This difference in solubility is likely due to the presence of the 
hydoxy group in 6a and is an additional benefit of incorporating the alcohol functionality, as a wide 
solubility range increases the scope for potential catalytic applications. The synthesis of ether-
functionalised ruthenium complexes was probed using triazolium 2 in an analogous procedure. While 
1H NMR spectroscopy and specifically the diagnostic shifts of both the ligand and the p-cymene 
resonances suggest the formation of the product in the crude reaction mixture, the product was unstable 
and decomposed during purification, which prevented the isolation of a pure sample. 
 
 
Scheme 2 Synthesis of 1,2,3-triazolylidene ruthenium(II) complexes 6 and 7, and reference 
compound 8. 
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In addition to complexes 6a,b, the transmetallation procedure also yielded minor quantities of 
complexes 7 and 7’ as a result of the Ag-mediated degradation of the C4-wingtip group of triazolium 
salt 1, analogously to complexes 4. The nature of these complexes was confirmed by NMR spectroscopy 
and elemental analysis. Two sets of resonances were observed in the 1H and 13C spectra, confirming the 
presence of both regioisomers in a ca. 1:1 mixture. Purification by column chromatography provided 
pure complex 7 in small quantities, yet sufficient for unambiguous NMR characterisation of this 
complex. Consequently, this data in combination with NOESY experiments allowed also the 1H and 
13C resonances of complex 7’ to be assigned from the mixed sample. The 1H NMR spectrum of 
complexes 7 and 7’ features two resonances at δH = 7.63 and 7.59 ppm which are diagnostic for the loss 
of the C4-wingtip group. The triazolylidene 13C NMR resonances of complex 7 were slightly deshielded 
when compared to the isomer 7’ (δC = 166.0 and 133.8 vs. 166.4 and 134.5). These data reflect the 
closely related structures of 7 and 7’ and the similar donor properties of the methyl and n-butyl groups.  
The monodentate triazolylidene complex 6a and the C,O-bidentate triazolylidene ruthenium 
complex 6b were readily distinguished by their Ccym.H resonances in the 5.9–4.5 ppm range, and in 
particular by the resonance of the NCH2 group, which appears as a triplet at δH = 4.56 in 6a, while in 
6b this group gives rise to a multiplet at δH = 4.68–4.52. We note that the 1H NMR spectrum of 6b does 
not reveal diastereotopic resonances for the C(CH3)2 group of the p-cymene, even though the 
ruthenium(II) centre is stereogenic. The 13C spectra revealed no distinct differences between 6a and 6b, 
and the carbenic resonances of these complexes are within the range reported for similar triazolylidene 
ruthenium complexes (δC = 164.8 and 163.9 for 6a and 6b respectively).[14a,15,16,23] NMR data was 
not sufficient to distinguish the structural motifs of 6a and 6b, and analogously to complexes 3 and 5 
chloride scavenging reactions were used to identified the denticity of the triazolylidene ligand. Thus, 
addition of AgBF4 (1 equivalent, CH2Cl2) or NH4BF4 (1 equivalent, acetone) to complex 6a yielded 6b, 
as evidenced by the diagnostic shift and splitting of the NCH2 resonance in the 1H NMR spectrum. 
When NaBPh4 was used to abstract the chloride ligand from complex 6a, the observed 1:1 ratio between 
the BPh4– anion and the ligand NMR resonances confirmed the monocationic nature of 6b. Conversely, 
complex 6b was converted to complex 6a by the addition of brine to an aqueous solution of 6b followed 
by extraction with CH2Cl2. This methodology is analogous to the aqueous purification of the reaction 
mixture (see above), which yielded exclusively complex 6a. Accordingly, the presence of excess 
chloride ions induces metallacycle ring opening and the transformation of the chelate ligand in 6b to a 
monodentate bonding mode in 6a. The reversible interconversion of 6a and 6b demonstrates that the 
hydroxy group provides a hemilabile ligand site. Finally, D2O exchange experiments confirmed the 
presence of acidic OH groups in both complexes 6a and 6b by the disappearance of the 1H NMR 
resonances at δH = 9.46 and 9.34, respectively (D6-DMSO solutions, Fig. S2–S4). These data confirm 
that the C,O-bidentate ligand in complex 6b is formally neutral. 
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Transformation of 6b to 6a in aqueous media suggested that the chelating and the non-chelating 
triazolylidene binding mode may be interconvertible depending on the polarity of the solvent. NMR 
spectroscopic investigations of pure complexes 6a and 6b revealed no equilibrium in CDCl3 and CD2Cl2 
and each complex displayed its own characteristic resonance pattern for the cymene and NCH2 group 
(vida supra). In CD3OD, the aromatic cymene resonances of complex 6a are relatively broad, while the 
resolution was unaltered for complex 6b. The broadening observed in complex 6a may hint towards an 
exchange in the ruthenium coordination sphere and competitive MeOH coordination (Fig. S4). In D6–
DMSO, 6a and 6b have identical 1H NMR spectra (Fig. S2), indicating the formation of a cationic 
complex involving either C,O-bidentate triazolylidene chelation as in 6b, or a Ru–DMSO bond 
formation by displacement of the chloride and the chelating-hydroxy ligands of 6a and 6b, respectively. 
Further characterization of this species was prevented by the gradual decomposition of both 6a and 6b 
in DMSO solution, evidenced by the appearance of 1H resonances corresponding to free p-cymene 
already within the first few min. When dissolved in CDCl3, CD2Cl2, or CD3OD, complexes 6a,b 
exhibited better stability and p-cymene loss was only observed after extended time periods (ca. 24 h, 
i.e. when cymene loss was complete in DMSO). For comparative purposes, D6-DMSO solutions of the 
known[15a] ruthenium complex [Ru(1,4-dibutyl-triazolylidene)Cl2(cymene)] as analogue of 
complexes 6a,b displayed only ca. 2% free p-cymene even 2 days after sample preparation. Cymene 
loss is presumably promoted by the coordinating nature of the wingtip group, which is also corroborated 
by instability of related triazolylidene ruthenium(II) complexes containing an imine wingtip 
group.[15b] 
 
Catalytic transfer hydrogenation. The pendant O-functionalities in complexes 3,5 and 6 provide 
opportunities for cooperative metal-ligand interaction and proton-shuttling, which is particularly 
beneficial in hydrogen transfer reactions.[4c,8,24] The catalytic activity of the novel iridium complexes 
3–5 was therefore evaluated in transfer hydrogenation using standard reaction conditions, i.e. refluxing 
iPrOH as the sacrificial hydrogen source, KOH (10 mol% relative to the substrate) and benzophenone 
as model substrate.[25] An initial run with complex 3a as catalyst precursor at 1 mol% loading produced 
the product alcohol in a moderate 67% yield after 8 h (Table 2, entry 1). Increasing the catalysts loading 
to 2 mol% enhanced the performance and gave quantitative conversions when using the O-
functionalised iridium complexes 3a and 3b (entries 2,3). A time conversion profile indicated no 
significant difference in performance of these two complexes (Fig. 2), suggesting that the catalytically 
active species formed from 3a and 3b is identical. In comparison, complex 4 containing an 
unfunctionalised triazolylidene ligand only achieved 39% conversion within the same reaction time. 
This substantial reactivity difference emphasizes the beneficial role of the hydroxy functionality. 
Moreover, it indicates that the functional wingtip group is resistant to base-mediated degradation as 
observed in the presence of Ag2O (cf. formation of 4 during the metalation process). The presence of 
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an ether functionality as triazolylidene wingtip group as in complex 5a improves the activity of the 
iridium centre slightly when compared to the unfunctionalised ligand in 4 (65%, entry 4), though the 
performanc is still significantly lower than in the presence of a hydroxy group. These data suggest that 
the hydroxy group plays a distinct role, likely in the formation of a metal-bound alkoxide as an anionic 
C,O-bidentate chelate.[26] Such alkoxide formation increases the electron density at the iridium centre 
and therefore enhance its catalytic activity in transfer hydrogenation. Alternatively, the alkoxy group 
may facilitate formal dihydrogen abstraction from iPrOH via an outer sphere mechanism, involving 
transfer of the hydride to the iridium centre and proton transfer to the ligand oxygen.[8d,e] In 
stoichiometric experiments, reaction of 3b with Cs2CO3 as a base indeed revealed formation of a new 
species with a 1H resonance pattern distinct from 3a and 3b (e.g. NCH2 appears as a multiplet at 4.27–
4.18 ppm), which has been assigned tentatively to the deprotonated alkoxide species. 
 
 
Figure 2 Time-dependent profile for the catalytic transfer hydrogenation of benzophenone with 
complexes 3–5 (solid lines: S/C/B ratio 50:1:5, 2 mol% complex; dashed lines: S/C/B ratio 100:1:10, 1 
mol% complex).  
 
Table 2 Catalytic transfer hydrogenation of benzophenone.a 
 
entry cat. mol% time (h) / conv (%)b Time (h) / conv. (%)b TOF50 (h–1)c 
1 3a 1 2 / 33 8 / 67 12 
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2 3a 2 2 / 46 8 / 96 12 
3 3b 2 2 / 48 8 / 97 12 
4 4/4’ 2 2 / 13 8 / 35 2 
5 5a 2 2 / 26 8 / 65 4 
6 6a 1 0.5 / 78 1.5 / 97 210 
7 6b 1 0.5 / 76 1.5 / 98 200 
8 8 1 0.5 / 95 1.5 / 98 370 
a General reaction conditions: Benzophenone (0.5 mmol or 1.0 mmol), KOH (10 mol%), [Ir] (0.01 
mmol), 2-propanol (5 mL), reflux temperature; b Conversions determined by 1H NMR spectroscopy 
using mesitylene as internal standard, averaged over 2 runs; c TOF50 determined at 50% conversion.  
 
The ruthenium complexes 6a,b were considerably more active than their iridium analogues in 
transfer hydrogenation under otherwise identical conditions and reached full conversion within 1 h 
when used at 1 mol% loading (Table 2, entries 6,7). Again, both complexes showed a reactivity profile 
that is identical within standard errors (Fig. S1). The analogous ruthenium complex 8 containing a 1,4-
dibutyl-triazolylidene ligand[15a] was evaluated for comparison and reached 92% conversion within 
15 min (cf. 51% for complexes 6a and 6b) and essentially complete conversion after 30 min (entry 8). 
The higher activity of complex 8 (TOF = 370 h–1 vs about 200 h–1 for complexes 6a,b) indicates no 
beneficial role of the hydroxy group in the ruthenium system. These data are in agreement with an inner 
sphere monohydride mechanism,[27] in which the critical hydride species is formed via b-hydrogen 
elimination of metal-coordinated isopropoxide without any participation of ancillary ligands.  
Previous studies revealed that triazolylidene ruthenium(II) complexes are more active transfer 
hydrogenation catalysts than their iridium(III) analogues.[16b,c] Likewise, ruthenium complex 6a 
reaches nearly quantitative conversion within 1 h, and is more than an order of magnitude more active 
than its iridium analogue 3a which reaches only 18% conversion in the same time (TOF 210 h–1 vs 12 
h–1). The different role of the hydroxy wingtip group in the iridium and ruthenium complexes suggests 
a different pathway for dihydrogen transfer from the iPrOH donor to the catalyst, and due to the 
microscopic reversibility, also from the catalyst to the substrate ketone. However, the hydrogen 
substituent of the triazolylidene in complex 4 may be susceptible to deprotonation thereby deactivating 
the catalyst. Therefore, it is clear that the catalytic activity of complexes 7/7’ or the iridium analogue 
of complex 8 is needed to make an unambiguous comparison between working modes of the iridium 
and ruthenium complexes with O-functionalised triazolylidene ligands, and will be included in future 
work. Finally, in comparison to other 1,2,3-triazolydene complexes employed in transfer 
hydrogenation, the iridium complexes reported here perform only moderately, while the ruthenium 
complexes are comparable to other carbene-based systems.[16]  
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Conclusions 
O-functionalised 1,2,3-triazolyldiene iridium(III) and ruthenium(II) complexes were synthesised 
and applied in transfer hydrogenation. Ether- and hydroxy-substituted 1,2,3-triazolylidene iridium(III) 
complexes were isolated with the ligand both in mono- and bidentate coordination mode. Also, 
monodentate and C,O-bendate, hydroxy-functionalised 1,2,3-triazolylidene ruthenium complexes are 
described. The monodentate complexes were converted to the chelating species by chloride abstraction 
and vice versa, the chelates were transformed into monodentate ligands in the presence of excess halide. 
Transfer hydrogenation studies revealed that pendant hydroxy-donors substantially enhance the 
catalytic activity of the triazolylidene iridium(III) catalyst while analogous hydroxy-functionalised 
triazolylidene ruthenium(II) complexes did not outperform analogous unfunctionalised complexes. 
Generally, activity was much higher for the ruthenium(II) complexes than the iridium(III) homologues, 
which hints towards diverging activation mechanisms. Caution is therefore required when generalising 
beneficial ligand features. Future outlooks include a detailed investigation into the activity of the 
ruthenium complexes in transfer hydrogenation to conclusively determine the influence of the hydroxy-
group. Also, applications in base free oxidations and N-alkylation reactions pose exciting avenues of 
research to determine the influence of O-functionality in other (de)hydrogenation processes.  
 
Experimental Section 
General Procedures. Ag2O was used after regeneration by heating >160 °C under vacuum. 
[Ir(Cp*)Cl2]2,[28] 1-butyl-4-(CMe2OH)-triazole,[18d] 1,[18d] and 8 [15a] were prepared according to 
reported procedures. All other reagents were used as received from commercial suppliers. NMR spectra 
were recorded on Bruker and Varian spectrometers operating at room temperature. Chemical shifts (δ 
in ppm, coupling constants J in Hz) were referenced to residual solvent resonances and are given 
downfield from SiMe4. Elemental analysis and mass spectrometry were carried out by the 
microanalytical services of University College Dublin and University of Bern. 
Triazolium salt 2. Under a N2 atmosphere, 1-butyl-4-(CMe2OH)-triazole (0.914 g, 5.0 mmol) was 
dissolved in dry THF (20 mL) and cooled to 0 °C. To this solution, NaH (60% in mineral oil, 0.30 g, 
7.5 mmol) was added in 3 portions. The temperature was maintained at 0 °C for 15 min, after which the 
reaction mixture was allowed to stir at room temperature for 1 h. Iodomethane (0.50 mL, 8.0 mmol) 
was added to the reaction mixture, which was stirred for a further 1 h. Then H2O (100 mL) was slowly 
added and the mixture was stirred for 30 min. The reaction mixture was extracted with Et2O (3 x 100 
mL). The organic fractions were combined and washed with brine (2 x 100 mL), dried with Na2SO4, 
13	
	
filtered and all volatiles removed under reduced pressure, yielding 1-butyl-4-(CMe2OMe)-triazole as a 
pale yellow oil. This intermediate was purified by column chromatography (SiO2; EtOAc/pentane, 2:1), 
however the crude form was suitable to be used for the next step. 1H NMR (400 MHz, CDCl3): δ 7.43 
(s, 1H, CtrzH), 4.34 (t, 3JHH = 7.3 Hz, 2H, NCH2), 3.14 (s, 3H, OCH3), 1.95–1.83 (m, 2H, NCH2CH2), 
1.61 (s, 6H, C(CH3)2), 1.43–1.30 (m, 2H, CH2CH3), 0.96 (t, 3JHH = 7.4 Hz, 3H, CH2CH3) 13C{1H} NMR 
(101 MHz, CDCl3): δ 152.7 (CtrzC), 120.4 (CtrzH), 73.1 (C(CH3)2), 50.7 (OCH3), 50.1 (NCH2), 32.4 
(NCH2CH2), 26.7 (C(CH3)2) 19.9 (CH2CH3), 13.6 (CH2CH3). The 1-butyl-4-(CMe2OMe)-triazole was 
dissolved in dry CH2Cl2 (30 mL). Then Me3OBF4 (0.845 g, 5.0 mmol) was added and the suspension 
stirred for 20 h under a N2 atmosphere. MeOH (5 mL) was added and stirring continued for 30 min. All 
volatiles were removed under reduced pressure and the residual brown oil was dissolved in a minimal 
amount of CH2Cl2 and precipitated by addition of pentane (200 mL). The residue was collected by 
decantation and dried under reduced pressure. The solid was then dissolved in CH2Cl2 (50 mL) and 
stirred with activated carbon (100–325 mesh, 6 g) for 10 min. The suspension was filtered over Celite, 
and volatiles removed under reduced pressure. The residue was redissolved in a minimum amount of 
CH2Cl2 and added dropwise to cold Et2O with vigorous stirring. The white precipitate was collected by 
decantation and thoroughly dried to yield the title product as a white solid (1.11 g, 74%). 1H NMR (400 
MHz, CDCl3): δ 8.60 (s, 1H, CtrzH), 4.60 (t, 3JHH = 7.5 Hz, 2H, NCH2), 4.36 (s, 3H, NCH3), 3.20 (s, 3H, 
OCH3), 2.07–19.5 (m, 2H, NCH2CH2), 1.70 (s, 6H, C(CH3)2), 1.48–1.36 (m, 2H, CH2CH3), 0.98 (t, 3JHH 
= 7.4 Hz, 3H, CH2CH3). 13C{1H} NMR (101 MHz, CDCl3): δ 146.9 (CtrzC), 130.0 (CtrzH), 72.8 
(C(CH3)2), 54.2 (NCH2), 51.4 (OCH3), 39.7 (NCH3), 31.1 (NCH2CH2), 25.5 (C(CH3)2), 19.6 (CH2CH3), 
13.4 (CH2CH3) HRMS (ESI +): m/z Found 212.1757 [M–BF4]+ (calcd for C11H22N3O, 212.1763) Anal. 
Calc. for C11H22BF4N3O: C, 44.17; H, 7.41; N, 14.05%. Found: C, 43.74, H, 7.27; N, 13.96%. 
Complexes 3 and 4. A suspension of 1 (170 mg, 0.60 mmol), Me4NCl (66 mg, 0.60 mmol ), Ag2O 
(280 mg, 1.2 mmol ) in CH2Cl2/MeCN (1:1 v/v, 10 mL) was stirred protected from light for 16 h. The 
suspension was filtered through Celite, eluted with CH2Cl2 (100 mL), and [Ir(Cp*)Cl2]2 (180 mg, 0.23 
mmol) added and the reaction mixtures stirred for 5 h protected from light. The reaction mixture was 
filtered over Celite, eluting with CH2Cl2 and the volatiles were removed under reduced pressure to yield 
the crude reaction mixture. Purification by column chromatography (SiO2; CH2Cl2/MeOH gradient, 
20:1 to 5:1) yielded complex 3a (yellow solid, 120 mg, 43%), 3b (yellow-brown solid, 58 mg, 20%) 
and complexes 4 and 4’(1:1 mixture, hydroscopic yellow solid, 43 mg, 17%).  
Analytical data of complex 3a. 1H NMR (400 MHz, CD2Cl2): δ 6.21 (br, 1H, OH), 4.93 (br, 1H, 
NCH2), 4.09 (s, 4H, NCH3 and NCH2), 2.04 (br s, 2H, NCH2CH2), 1.64 (s, 6H, C(CH3)2), 1.56 (s, 15H, 
CCpCH3), 1.50–1.44 (m, 2H, CH2CH3), 1.00 (t, 3JHH = 7.4 Hz, 3H, CH2CH3). 13C{1H} NMR (400 MHz, 
CD2Cl2): δ 152.9 (Ctrz), 145.5 (Ctrz), 88.7 (CCp), 69.0 (C(CH3)2), 55.2 (NCH2), 39.7 (NCH3), 33.4 
(NCH2CH2), 30.5 (br, C(CH3)2), 20.7 (CH2CH3), 14.2 (CH2CH3), 9.5 (CCpCH3). HRMS (ESI+): m/z 
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Found 560.2002 [M–Cl]+ (cald for C20H34ON3ClIr, 560.2014). Anal. Calcd for C20H34N3Cl2IrO: C, 
40.33; H, 5.75; N, 7.05%; Found: C, 40.04; H, 5.64; N, 6.95%. 
Analytical data of complex 3b. 1H NMR (400 MHz, CD2Cl2): δ 4.45 (br, 2H, NCH2), 4.10 (s, 3H, 
NCH3), 3.39 (br, 1H, OH), 2.05–1.93 (m, 2H, NCH2CH2), 1.73 (s, 15H, CCpCH3), 1.65 (s, 6H, 
(C(CH3)2), 1.47–1.33 (m, 2H, CH2CH3), 0.98 (t, 3JHH = 7.4 Hz, CH2CH3). 13C{1H} NMR (101 MHz, 
CD2Cl2): 157.2 (CtrzC), 154.1 (C–Ir), 89.4 (CCp), 77.6 (C(CH3)2), 54.1 (NCH2), 37.7 (NCH3), 32.4 
(NCH2CH2), 28.7 (C(CH3)2), 20.3 (CH2CH3), 13.9 (CH2CH3), 10.2 (CCpCH3). HRMS (ESI+): m/z Found 
524.2240 [M–H–Cl–BF4]+ (cald for C20H33ON3Ir, 524.2247). Despite numerous attempts and spectral 
purity of the compound (see Supplementary Material), no satisfactory microanalysis data could be 
obtained. Closest values are: Anal. Calcd for C20H34BClF4IrN3O: C, 37.13; H, 5.30; N, 6.49%; Found: 
C, 38.14; H, 5.48; N, 6.54%. 
Analytical data of complex 4. 1H NMR (400 MHz, CD2Cl2): δ 7.49 (s, 1H, CtrzH), 4.50–4.46 (m, 
2H, NCH2), 4.05 (s, 3H, NCH3), 2.09–1.98 (m, 2H, NCH2CH2), 1.59 or 1.58 (s, 15H, CpCH3), 1.53–
1.42 (m, 2H, CH2CH3), 0.99 (t, 3JHH = 7.5 Hz, 3H, CH2CH3). 13C{1H} NMR (101 MHz, CD2Cl2): δ 
148.4 (Ctrz–Ir), 134.8 (CtrzC), 88.3 (CCp), 53.7 (NCH2), 38.8 (NCH3), 31.9 (NCH2CH2), 20.2 (CH2CH3), 
13.7 (CH2CH3), 9.13 or 9.12 (CCpCH3). 
Analytical data of complex 4’. 1H NMR (400 MHz, CD2Cl2): δ 7.51 (s, 1H, CtrzH), 4.29 (t, 2H, 3JHH 
= 7.3 Hz, NCH2), 4.25 (s, 3H, NCH3), 2.09–1.98 (m, 2H, NCH2CH2), 1.59 or 1.58 (2 x s, 15H, CpCH3), 
1.42–1.30 (m, 2H, CH2CH3), 0.97 (t, 3JHH = 7.4 Hz, 3H, CH2CH3). 13C{1H} NMR (101 MHz, CD2Cl2): 
δ 147.9 (Ctrz–Ir), 134.1 (CtrzC), 88.3 (CCp), 52.4 (NCH2), 40.3 (NCH3), 33.2 (NCH2CH2), 20.7 
(CH2CH3), 14.2 (CH2CH3), 9.13 or 9.12 (CCpCH3) HRMS (ESI+): m/z Found 502.1580 [M–Cl]+ (cald 
for C17H28N3ClIr, 502.1596). 
 
Complexes 5. A suspension of 2 (150 mg, 0.50 mmol), Me4NCl (55 mg, 0.50 mmol), Ag2O (233 mg, 
1.0 mmol) in MeCN (10 mL) was stirred protected from light for 24 h. The suspension was then filtered 
through Celite, and the volatiles removed under reduced pressure. The residue was suspended in CH2Cl2 
(20 mL) and [Ir(Cp*)Cl2]2 (150 mg, 0.19 mmol) was added. The reaction mixture was stirred for 5 h 
protected from light, then filtered over Celite, and all volatiles were removed under reduced pressure to 
yield the crude products. Purification by column chromatography (SiO2; CH2Cl2/MeOH gradient, 20:1 
to 10:1) yielded product 5a (100 mg, 42%) and 5b (62 mg, 23%) as orange solids.  
Analytical data of complex 5a. 1H NMR (400 MHz, CD2Cl2): 5.01–4.84 (m, 1H, NCH2), 4.19 (s, 3H, 
NCH3), 4.15–4.01 (m, 1H, NCH2), 3.06 (s, 3H, OCH3), 2.13–1.96 (m, 2H, NCH2CH2), 2.04 (s, 3H, 
C(CH3)2), 1.76 (s, 3H, C(CH3)2), 1.66–1.39 (m, 2H, CH2CH3), 1.53 (s, 15 H, C CpCH3) 1.01 (t, 3H, 
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CH2CH3). 13C{1H} NMR (101 MHz, CD2Cl2): 150.2 (CtrzC), 144.7 (Ctrz–Ir), 88.4 (CCp), 76.5 (C(CH3)2), 
56.1 (NCH2), 50.0 (OCH3), 41.0 (NCH3), 33.6 (NCH2CH2), 28.6, 25.3 (C(CH3)2), 20.8 (CH2CH3), 14.3 
(CH2CH3), 9.70 (CCpCH3). HRMS (ESI+): m/z Found 574.2161 [M–Cl]+ (cald for C21H36ON3ClIr, 
574.2171) Anal. Calcd for C21H26N3Cl2IrO: C, 41.37; H, 5.95; N, 6.89%; Found: C, 41.43; H, 5.95; N, 
6.74%.  
Analytical data of complex 5b. 1H NMR (400 MHz, CD2Cl2): δ 4.57–4.49, 4.37–4.27 (2 x m, 1H, 
NCH2), 4.13 (s, 3H, NCH3), 3.70 (s, 3H, OCH3), 2.02–1.85 (m, 2H, NCH2CH2), 1.67 (s, 15H, CCpCH3), 
1.61, 1.60 (2 x s, 3H, C(CH3)2), 1.41–1.30 (m, 2H, CH2CH3), 0.95 (t, 3JHH = 7.4 Hz, 3H, CH2CH3). 
13C{1H} NMR (101 MHz, CD2Cl2): 153.0 (Ctrz–Ir), 151.5 (CtrzC), 89.9 (CCp), 81.5 (C(CH3)2), 54.8 
(OCH3), 54.3 (NCH2), 38.3 (NCH3), 32.3 (NCH2CH2), 25.2, 24.6 (2 x C(CH3)2), 20.2 (CH2CH3), 13.9 
(CH2CH3), 10.2 (CCpCH3). HRMS (ESI+): m/z Found 574.2158 [M–BF4]+ (cald for C21H36ON3ClIr, 
574.2171). Elemental analyses consistently showed high C values (by 1-2% and low H values (1%), 
even though the compounds were NMR spectroscopically pure. 
Complexes 6 and 7. A suspension of 1 (170 mg, 0.60 mmol), Me4NCl (66 mg, 0.60 mmol ), Ag2O 
(280 mg, 1.2 mmol ) in CH2Cl2/MeCN (1:1 v/v, 10 mL) was stirred protected from light for 16 h. The 
suspension was filtered through Celite, eluted with CH2Cl2 (100 mL), and [Ru(p-cymene)Cl2]2 (110 mg, 
0.18 mmol) added. The reaction mixture was stirred for 2 h protected from light, filtered over Celite, 
evaporated to dryness under reduced pressure. The crude reaction mixture was purified by column 
chromatography (SiO2; CH2Cl2/MeOH gradient, 20:1 to 5:1), which yielded complex 6a (50 mg, 28%) 
and complex 6b (57 mg, 28%) both as a red-brown, hygroscopic solids, and complexes 7 and 7’ in a 
1:1 mixture as a brown, hygroscopic solid (22.5 mg, 14%).  
Alternately complex 6a was isolated selectively by applying an alternative purification procedure. 
The crude reaction mixture was suspended in CH2Cl2 (100 mL) and extracted with H2O (100 mL). 
CH2Cl2 (100 mL) was added to the aqueous phase followed by brine (200 mL) and the mixture 
extracted. The organic phase was dried over Na2SO4, filtered and the volatiles were removed under 
reduced pressure. Residual [Ru(p-cymene)Cl2]2 was removed from this residue by washing a CH2Cl2 
(100 mL) solution of the product with several amounts of saturated NH4Claq until the aqueous phase 
was colourless. The crude product was purified by column chromatography (SiO2; CH2Cl2/MeOH, 
10:1-5:1 gradient), yielding 6a as a red-brown, hygroscopic solid (104 mg, 57%) 
Analytical data of complex 6a. 1H NMR (400 MHz, CD2Cl2): 5.82, 5.73, 5.68, 5.18 (4 x br. s, 1H, 
Hcym), 4.56 (t,3JHH = 7.4 Hz, NCH2), 3.97 (s, 3H, NCH3), 2.81–2.66 (m, 1H, CHMe2), 2.14 (s, 3H, 
CcymCH3), 2.11–1.99 (m, 2H, NCH2CH2), 1.62, 1.54 (2 x br. s, 3H, C(CH3)2), 1.52–1.38 (m, 2H, 
CH2CH3), 1.17 (d,3JHH = 6.7 Hz, 6H, CH(CH3)2), 1.01 (t, 3JHH = 7.4 Hz, CH2CH3). 13C{1H} NMR (101 
MHz, CD2Cl2): δ 164.8 (Ctrz–Ru), 152.3 (CtrzC), 104.5 (CcymCH), 100.7 (CcymCH3), 86.5 , 82.0, 79.0 (4 
x CcymH), 76.1 (C(CH3)2), 54.3 (NCH2), 37.1 (NCH3), 32.3 (NCH2CH2), 31.5 (CHMe2), 29.3, 28.9 (2 
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x C(CH3)2), 23.3, 22.3 (2 x CH(CH3)2), 20.5 (CH2CH3), 19.3 (CcymCH3), 13.9 (CH2CH3). HRMS 
(ESI+): m/z Found 468.1342 [M–Cl]+ (calcd. for C20H33ON3ClRu, 468.1350) Anal. Calcd for 
C20H33N3Cl2ORu: C, 46.35; H, 6.44; N, 8.01%; Found: C, 46.48; H, 6.50; N, 7.88%. 
Analytical data of complex 6b. 1H NMR (400 MHz, CD2Cl2): δ 5.85–5.79 (m, 2H, Hcym), 5.49 (d, 
3JHH = 6.0 Hz, 1H, Hcym), 5.18 (d, 3JHH = 5.9 Hz, 1H, Hcym), 4.68–4.52(m, 2H, NCH2), 4.01 (s, 3H, 
NCH3), 2.79–2.64 (m, 1H, CHMe2), 2.16 (s, 3H, CcymCH3), 2.09–1.96 (m, 2H, NCH2CH2), 1.58 (s, 6H, 
C(CH3)2), 1.51–1.36 (m, 2H, CH2CH3), 1.21 (d, 3JHH = 6.6 Hz, 6H, CH(CH3)2), 1.01 (t, 3JHH = 7.3 Hz, 
3H, CH2CH3). 13C{1H} NMR (101 MHz, CD2Cl2): δ 163.9 (Ctrz–Ru), 149.0 (CtrzC), 106.4 (CcymCH3), 
100.8 (CcymCH), 86.3, 82.0, 80.5, 79.0 (4 x CcymH), 77.5 (C(CH3)2), 54.6 (NCH2), 37.5 (NCH3), 32.2 
(NCH2CH2), 31.7 (CHMe2), 28.5, 28.3 (2 x C(CH3)2), 23.1, 22.2 (2 x CH(CH3)2), 20.5 (CH2CH3), 19.3 
(CcymCH3), 13.9 (CH2CH3). HRMS (ESI+): m/z Found 468.1342 [M–BF4]+ (calcd. for C20H33ON3ClRu, 
468.1350). Like for the other C,O-bidentate triazolylidene complexes, no satisfactory microanalysis 
could be obtained for this complex. 
 Analytical data of complex 7. 1H NMR (400 MHz, CD2Cl2): δ 7.63 (s, 1H, CtrzH), 5.28 (d, 3JHH = 
5.9 Hz, 2H, Hcym), 5.14 (d, 3JHH = 5.8 Hz, 2H, Hcym), 4.32–4.24 (m, 5H,NCH3 and NCH2), 2.65 (hept, 
3JHH = 6.9 Hz,1H, CHMe2), 2.09 (s, 3H, CcymCH3), 1.96–1.86 (m, 2H, NCH2CH2), 1.45–1.31 (m, 2H, 
CH2CH3), 1.19 (d, 3JHH = 6.9 Hz, 6H, CH(CH3)2), 0.97 (t, 3H, 3JHH = 7.4 Hz, CH2CH3). 13C{1H} NMR 
(101 MHz, CD2Cl2): δ 166.0 (Ctrz–Ru), 133.8 (CtrzH), 104.1 (CcymCH), 100.7 (CcymCH3), 84.8, 84.3 (2 
x CcymH), 52.3 (NCH2), 41.0 (NCH3), 31.9 (NCH2CH2), 31.3 (CHMe2), 22.6 (CH(CH3)), 20.2 
(CH2CH3), 18.7 (CcymCH3), 13.7 (CH2CH3).  
Analytical data of complex 7’. 1H NMR (400 MHz, CD2Cl2): δ 7.59 (s, 1H, CtrzH), 5.27 (d, 3JHH = 
5.9 Hz, 2H, Hcym), 5.12 (d, 3JHH = 6.1 Hz, 2H, Hcym), 4.58–4.49 (m, 2H, NCH2), 4.04 (s, 3H, NCH3), 
2.76–2.66 (m, 1H, CHMe2), 2.08 (s, 3H, CcymCH3), 2.07–1.96 (m, 2H, NCH2CH2), 1.55–1.44 (m, 2H, 
CH2CH3), 1.20 (d, 3JHH = 7.0 Hz, 6H, CH(CH3)2), 1.01 (t, 3JHH = 7.4 Hz, 3H, CH2CH3). 13C{1H} NMR 
(101 MHz, CD2Cl2): δ 166.4 (Ctrz–Ru), 134.5 (CtrzH), 104.3 (CcymCH), 99.6 (CcymCH3), 84.9, 84.5 (2 x 
CcymH), 52.3 (NCH2), 38.8 (NCH3), 33.8 (NCH2CH2), 31.2 (CHMe2), 22.6 (CH(CH3)2), 20.7 (CH2CH3), 
18.7 (CcymCH3), 14.2 (CH2CH3). HRMS (ESI+): m/z Found 410.0929 [M–Cl]+ (cald for C17H27N3ClRu, 
410.0932) Anal. Calcd for C17H27N3Cl2Ru: C, 45.84; H, 6.11; N, 9.43%; Found: C, 45.85; H, 6.09; N, 
9.03%. 
 
Chelation of monodentate ligands. AgBF4 as chloride scavenging agent. To a solution of the 
corresponding metal complex (1 eq.) in CH2Cl2 (2 mL) was added AgBF4 (1 eq.) followed by CH2Cl2 
(3 mL). The reaction mixture was stirred for 15 min while protected from light, filtered over Celite and 
the volatiles were removed under reduced pressure. Further purification included gradient column 
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chromatography (SiO2; CH2Cl2 to MeOH). Alternatively, a solution of the metal complex (1 eq.) in 
acetone (2 mL) was treated with (NH4)BF4 or NaBPh4 (1 eq.) in acetone (3 mL). The reaction mixture 
was stirred for 18 h, all volatiles were removed under reduced pressure, and the residue was suspended 
in CH2Cl2 and filtered over Celite.  
General procedure for catalytic transfer hydrogenation. In a one-necked round bottom flask 
metal complex (1.0 mmol), 2-propanol (5 mL) and mesitylene (0.36 mmol or 0.72 mmol) were mixed 
and aqueous KOH (2.0 M, 0.05 mmol or 0.1 mmol, 10 mol% relative to substrate) added and the mixture 
heated to a vigorous reflux for 10 minutes. Benzophenone (0.5 mmol or 1.0 mmol) was added, and 
aliquots (0.1 mL) were taken and directly dissolved in CDCl3 (0.7 mL) and analysed by 1H NMR 
spectroscopy, using mesitylene as internal standard.  
 
Crystal Structure Determination. Crystal data of 3a, 3b, and 5a were collected on a Oxford 
Diffraction SuperNova area-detector diffractometer using mirror optics monochromated Mo Kα 
radiation (λ = 0.71073 Å) and Al filtered. Data reduction was performed using the CrysAlisPro 
program.[29] The intensities were corrected for Lorentz and polarization effects, and an absorption 
correction based on the multi-scan method using SCALE3 ABSPACK in CrysAlisPro[29] was applied. 
The structure was solved by direct methods using SHELXT,[30] which revealed the positions of all non-
hydrogen atoms of the title compound. The non-hydrogen atoms were refined anisotropically. All H-
atoms were placed in geometrically calculated positions and refined using a riding model. Refinement 
of the structure was carried out on F2 using full-matrix least-squares procedures, which minimized the 
function Σw(Fo2 – Fc2)2. The weighting scheme was based on counting statistics and included a factor 
to downweight the intense reflections. All calculations were performed using the SHELXL-2014/7 
program.[31] Further crystallographic details are compiled in Table S1–S3. Crystallographic data for 
the structures of all compounds reported in this paper have been deposited with the Cambridge 
Crystallographic Data Centre (CCDC) as supplementary publication numbers numbers 1537332 (3a), 
1537334 (3b), and 1537333 (5a).  
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